论文部分内容阅读
由于药品定价机制不完善,我国药品价格管理的效果不明显,单纯的行政降价对部分制药企业的经营产生不利影响,而且也不能对高价药品的使用起到制约作用。因此,需要引入第三方组织,建立起由医保部门参与的药品价格管理机制。本文重点分析了我国药品价格管理与药品使用中存在的主要问题,及医保部门参与药品价格管理的必要性与可行性,并在此基础上提出了完善药品价格管理机制的对策建议。
Due to the imperfect pricing mechanism of medicines, the effect of drug price management in our country is not obvious. A simple administrative price-cutting has an adverse effect on the operation of some pharmaceutical enterprises, and can not restrict the use of expensive medicines. Therefore, the need to introduce third-party organizations to establish the medical insurance sector to participate in the drug price management mechanism. This article focuses on the analysis of the main problems in drug price management and drug use in China and the necessity and feasibility of the medical insurance sector in participating in drug price management. Based on this, the countermeasures and suggestions for improving drug price management mechanism are put forward.